Citi analyst Paul Lejuez lowered the firm’s price target on Bath & Body Works to $44 from $48 and keeps a Neutral rating on the shares post the Q4 results. The analyst says the reduced long-term outlook reflects structural cost headwinds.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BBWI:
- Third Point to Pursue a Proxy Fight with BBWI
- Bath & Body Works taking enterprise-wide effort to reduce expenses
- Bath & Body Works Reports Fourth Quarter and Full-Year 2022 Sales and Earnings Results
- Bath & Body Works responds to Third Point intent to nominate board candidates
- Bath & Body Works sees FY23 cont ops EPS $2.50-$3.00, consensus $3.16